Biostatistics is the application of statistical theory and methods to biological, medical, public health and related scientific data. It provides methods for designing studies, collecting observations, estimating quantities, testing hypotheses, modelling relationships, quantifying uncertainty and interpreting evidence. Biostatistics differs from ordinary descriptive data analysis because it explicitly addresses variability, sampling, probability and inference about populations from observed data. Its applications include clinical trials, epidemiology, genetics, genomics, public health surveillance, laboratory research, health services research and ecological studies.
Biostatisticians may contribute before data collection by designing experiments and determining sample sizes, during data collection by establishing quality control procedures, and after collection by conducting statistical analysis and interpreting results. The discipline is therefore closely connected to scientific methodology rather than being merely a collection of mathematical techniques.
Descriptive statistics provide initial summaries of observed data. Measures such as the mean, median and mode describe central tendency, while variance, standard deviation, interquartile range and related quantities describe dispersion. Frequency distributions, contingency tables and graphical methods help reveal patterns and unusual observations. Inferential statistics extend beyond the observed sample by using probability models to make statements about a wider population or underlying process.
Confidence intervals provide ranges of parameter values compatible with a statistical model and data under specified assumptions. Hypothesis tests evaluate data relative to a null hypothesis and produce measures such as p values, although a p value is not the probability that the null hypothesis is true. Statistical significance also does not automatically imply clinical or biological importance. Effect size, uncertainty, study design and practical context must be considered together. These distinctions are central to responsible interpretation of biostatistical results.
Study design is one of the most important areas of biostatistics because statistical analysis cannot fully correct for a fundamentally unsuitable design. Randomised controlled trials use random allocation to reduce systematic differences between treatment groups, while observational studies measure exposures and outcomes without controlled random assignment. Cohort studies follow defined groups over time, whereas case control studies generally begin with outcome status and investigate previous exposures.
Cross sectional studies measure variables at a particular period and are often useful for estimating prevalence. Sampling methods determine how observations are selected and affect generalisability. Confounding occurs when another variable is associated with both an exposure and an outcome and distorts their apparent relationship. Bias can arise through selection, measurement, nonresponse, missing data and other mechanisms. Blinding, randomisation, allocation concealment, appropriate control groups and prespecified analysis plans can reduce particular forms of bias.
Regression methods allow relationships between variables to be modelled while accounting for other factors. Linear regression is commonly used for continuous outcomes under appropriate assumptions, whereas logistic regression is suited to binary outcomes and produces measures such as odds ratios. Survival analysis examines time until an event while accounting for censoring, with methods such as Kaplan Meier estimation and proportional hazards modelling. Generalised linear models extend regression to different outcome distributions and link functions.
Longitudinal and repeated measures data require methods that account for correlation between observations from the same individual or experimental unit. Multilevel models can represent hierarchical structures such as patients within hospitals or measurements within individuals. Model selection should be guided by study design, scientific reasoning and validation rather than simply by automated optimisation of statistical fit. Poorly specified models can produce misleading estimates even when computational calculations are technically correct.
Biostatistics is essential to clinical research and evidence based medicine. Clinical trials require careful specification of endpoints, randomisation methods, sample size, analysis populations and statistical procedures before recruitment begins. Sample size calculations depend on assumptions concerning effect size, variability, significance thresholds, desired statistical power and study design. Interim analyses can require specialised statistical procedures because repeated examination of accumulating data can alter error rates if not appropriately planned.
Multiple comparisons arise when many outcomes, treatments or subgroups are examined, increasing the chance of false positive findings. Statistical methods can account for some of these issues through prespecified testing hierarchies or correction procedures. Missing data require careful assessment because the mechanism causing missingness can influence bias. Biostatistical analysis should therefore be interpreted in relation to the protocol, data collection process and biological plausibility rather than from isolated numerical outputs.
Modern biostatistics increasingly handles high dimensional and complex biological data. Genomic studies can involve millions of genetic variants, requiring methods for multiple testing, population structure and correlated observations. Survival data can include competing risks, time dependent variables and informative censoring. Bayesian methods provide a framework for combining prior information with observed data and generating posterior distributions, while frequentist methods interpret uncertainty through repeated sampling properties. Resampling methods such as bootstrapping can estimate sampling distributions when analytical formulas are inconvenient.
Causal inference uses study design and statistical frameworks to distinguish associations from questions concerning interventions or counterfactual outcomes. Machine learning can provide predictive models, but prediction and causal explanation are different objectives. High predictive accuracy does not by itself demonstrate that a variable causes an outcome. Biostatistical practice therefore increasingly integrates traditional statistical inference with computational methods while retaining attention to study design and scientific interpretation.
Common misunderstandings in biostatistics include treating correlation as proof of causation, interpreting statistical significance as practical importance, assuming a non significant result proves no effect exists, and interpreting confidence intervals as containing a fixed probability that the true parameter lies within them. Statistical tests are also sensitive to sample size, meaning a small effect can become statistically significant in a very large dataset while a meaningful effect can fail to reach conventional significance in a small study.
P values should therefore not be used as standalone measures of evidence or importance. Selection bias can remain even when sophisticated models are used, and adjustment for variables can sometimes introduce rather than remove bias if inappropriate variables are controlled. Reproducibility also depends on transparent reporting of analysis decisions, data processing and model assumptions. Biostatistics is consequently both mathematical and methodological, requiring understanding of probability, study design, measurement, biology and the limitations of statistical inference.
Biostatistics supports decision making across population health, clinical medicine and biological research by converting observations into quantified evidence. It can estimate disease prevalence, incidence, treatment effects, risk factors and survival distributions, while modelling uncertainty around those estimates. Public health surveillance uses statistical methods to identify changes in disease patterns and assess interventions. Epidemiological analyses can investigate relationships between exposures and health outcomes, although causal interpretation requires appropriate design and assumptions.
Biostatistical results are strongest when hypotheses, populations, outcomes and analysis methods are defined clearly before examining results. Transparency, reproducibility and appropriate communication of uncertainty are central principles. Statistical software makes complex analyses accessible but does not remove the need for methodological expertise. Ultimately, biostatistics provides a structured framework for distinguishing patterns that may reflect genuine biological or population processes from patterns that could arise through sampling variation, measurement error, bias or chance.
